GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Data up to Jan 2025
Total Citations Per Year
Abstract
References (75)
The PyMOL Molecular Graphics System
2002 • 18,218 citations
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
1998 • 15,791 citations
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
1995 • 5,246 citations
Specificity and mechanism of action of some commonly used protein kinase inhibitors
2000 • 4,109 citations
GSK-3: tricks of the trade for a multi-tasking kinase
2003 • 2,027 citations
The renaissance of GSK3
2001 • 1,459 citations
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
2001 • 1,408 citations
The specificities of protein kinase inhibitors: an update
2003 • 1,345 citations
Normal Table of Xenopus Laevis.
1968 • 1,185 citations
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
2003 • 1,145 citations
Chinese Drugs of Plant Origin
1992 • 992 citations
The Mouse Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis Formation
1997 • 908 citations
Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice
2001 • 865 citations
RIBBONS 2.0
1991 • 814 citations
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
1999 • 784 citations
Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease
2001 • 685 citations
Crystal Structure of Glycogen Synthase Kinase 3β
2001 • 636 citations
Implementation of molecular replacement in AMoRe
2001 • 621 citations
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation.
1993 • 616 citations
New aspects of Wnt signaling pathways in higher vertebrates
2001 • 550 citations
Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418
2003 • 504 citations
Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β
2003 • 481 citations
Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila
2002 • 474 citations
Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo
2003 • 470 citations
Databases in Protein Crystallography
1998 • 466 citations
Wnt Signaling Controls the Phosphorylation Status of β-Catenin
2002 • 464 citations
Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine
1992 • 454 citations
Glycogen synthase kinase 3: an emerging therapeutic target
2002 • 399 citations
Indirubin and Indigo Are Potent Aryl Hydrocarbon Receptor Ligands Present in Human Urine
2001 • 398 citations
Structure of GSK3beta reveals a primed phosphorylation mechanism.
2001 • 368 citations
Cyclic AMP Promotes Neuronal Survival by Phosphorylation of Glycogen Synthase Kinase 3β
2000 • 361 citations
Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25
2000 • 361 citations
Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
2001 • 361 citations
Regulation and localization of tyrosine216phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration
2000 • 359 citations
Head induction by simultaneous repression of Bmp and Wnt signalling in Xenopus
1997 • 351 citations
Wnt signaling in Xenopus embryos inhibits Bmp4 expression and activates neural development
1999 • 338 citations
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
2002 • 330 citations
Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils
2003 • 321 citations
Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced Apoptosis
2000 • 305 citations
Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex
2003 • 303 citations
Structural Characterization of the GSK-3β Active Site Using Selective and Non-selective ATP-mimetic Inhibitors
2003 • 289 citations
Oxidation of Indole by Cytochrome P450 Enzymes
2000 • 289 citations
Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in China
2002 • 274 citations
Structure and Regulation of the CDK5-p25nck5a Complex
2001 • 270 citations
Central Role of Glycogen Synthase Kinase-3β in Endoplasmic Reticulum Stress-induced Caspase-3 Activation
2002 • 258 citations
Glycogen synthase kinase‐3β, mood stabilizers, and neuroprotection
2002 • 241 citations
Further evidence that the inhibition of glycogen synthase kinase‐3β by IGF‐1 is mediated by PDK1/PKB‐induced phosphorylation of Ser‐9 and not by dephosphorylation of Tyr‐216
1997 • 232 citations
Expression and isolation of antimicrobial small molecules from soil DNA libraries.
2001 • 215 citations
Tyrian Purple: 6,6’-Dibromoindigo and Related Compounds
2001 • 214 citations
The homeobox gene Siamois is a target of the Wnt dorsalisation pathway and triggers organiser activity in the absence of mesoderm
1996 • 211 citations
Wnt signaling promotes oncogenic transformation by inhibiting c-Myc–induced apoptosis
2002 • 210 citations
Proapoptotic Stimuli Induce Nuclear Accumulation of Glycogen Synthase Kinase-3β
2001 • 209 citations
The GSK3β signaling cascade and neurodegenerative disease
2002 • 195 citations
Glycogen Synthase Kinase-3β Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington’s Disease Mutation
2002 • 187 citations
Glycogen Synthase Kinase-3β Activity Is Critical for Neuronal Death Caused by Inhibiting Phosphatidylinositol 3-Kinase or Akt but Not for Death Caused by Nerve Growth Factor Withdrawal
2000 • 182 citations
Identification of an indigo precursor from leaves of Isatis tinctoria (Woad)
2001 • 167 citations
Siamois is required for formation of Spemann’s organizer
1997 • 144 citations
Inhibitor Binding to Active and Inactive CDK2
2001 • 138 citations
TCF Is the Nuclear Effector of the β-Catenin Signal That Patterns the Sea Urchin Animal–Vegetal Axis
2000 • 137 citations
Intracellular Targets of Paullones
2002 • 136 citations
A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis
1997 • 134 citations
Über den Farbstoff des antiken Purpurs aus murex brandaris
1909 • 124 citations
Fibroblast Growth Factor 1 Regulates Signaling via the Glycogen Synthase Kinase-3β Pathway
2002 • 120 citations
GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity
2001 • 87 citations
GSK3β Signalling: Casting a Wide Net in Alzheimer’s Disease
2002 • 85 citations
Wnt signaling involvement in β-amyloid-dependent neurodegeneration
2002 • 76 citations
Recruitment of Dioxin Receptor to Active Transcription Sites
2002 • 70 citations
Intra-M Phase-promoting Factor Phosphorylation of Cyclin B at the Prophase/Metaphase Transition
1999 • 67 citations
Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?
2002 • 51 citations
Wnt signal transduction: kinase cogs in a nano-machine?
2002 • 49 citations
Biological Precursors and Genesis of Tyrian‐Purple
1971 • 47 citations
Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3′-phosphoadenosine-5′-phosphate phosphatase activities: a novel target of lithium therapy
2002 • 42 citations
Latest developments in crystallography and structure-based design of protein kinase inhibitors as drug candidates
2002 • 25 citations
Alzheimers Disease: Targets For Drug Development
2002 • 11 citations
Deleted Work
1955 • 0 citations